金石亚药获得硫酸氨基葡萄糖胶囊药品注册证书

Core Viewpoint - The company Jinshi Yiyao (300434.SZ) announced that its wholly-owned subsidiary, Zhejiang Yake Pharmaceutical Co., Ltd., has received the drug registration certificate for Glucosamine Sulfate Capsules from the National Medical Products Administration, which is considered equivalent to passing the consistency evaluation [1] Group 1: Product Information - Glucosamine Sulfate Capsules are classified as non-prescription analgesic drugs, indicated for primary and secondary osteoarthritis [1] - Glucosamine is a natural amino monosaccharide that serves as a precursor for the synthesis of proteoglycans, stimulating chondrocytes to produce proteoglycans with normal polymer structures [1] - The product enhances the repair capacity of chondrocytes, inhibits damaging enzymes such as collagenase and phospholipase A2, and prevents the production of superoxide free radicals in damaged cells, promoting the repair and reconstruction of cartilage matrix [1] Group 2: Therapeutic Benefits - The capsules can delay the pathological process of osteoarthritis pain and the progression of the disease, improve joint mobility, and alleviate pain [1]